Company intelligence / Profile preview

TheoremDx

Edina, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

As of 2017, TheoremDx developed rapid diagnostic test systems capable of differentiating tropical diseases with overlapping symptoms and screening for HIV, in collaboration with iBio to optimize protein components for their proprietary point-of-care platform; clinical validation status not publicly reported

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic deviceProteinPoint-of-care diagnostic system
Industry: Protein Biomarker Diagnostics

Partnerships

iBio (and its subsidiary iBio CDMO)

Beyond the preview

Go deeper on TheoremDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheoremDx.

Explore the full profile